DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Kris Licht - 2 Andrew Kelly - 1 Reckitt - 1 Bernstein - 1 Bruno Monteyne - 1 Richa Naidu - 1 Jason Neely - 1 David Evans - 1
Top related locs:
Manhattan , New York City U.S
Top related orgs:
Benckiser - 1 REUTERS - 1 Wednesday - 1 Thomson - 1

Search resuls for: "Kris Licht"


5 mentions found


☆ Better understanding of health outcomes may galvanize support for fighting climate change, Reckitt CEO says
  + stars: | 2023-12-01 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBetter understanding of health outcomes may galvanize support for fighting climate change, Reckitt CEO saysKris Licht, CEO of Reckitt, discusses the public health implications of climate change at the COP28 summit.
Persons: Kris Licht
☆ Reckitt misses like-for-like sales expectations, to launch $1.2 bln buyback
  + stars: | 2023-10-25 | by ( Richa Naidu | Thomson Reuters | London-Based Reporter Covering Retail | ) www.reuters.com   time to read: +2 min
The company's third-quarter sales volumes were also up against a tough comparative period from last year, when the recall of a rival U.S.-based company's infant formula boosted sales of Reckitt's Enfamil products there. Reckitt said quarterly like-for-like net sales rose 3.4%, behind the 3.7% growth analysts had expected in a company-supplied poll. Rival consumer products makers who have raised prices over the past two years have said in recent weeks that sales volumes could soon see improvements. The price/mix for Reckitt's products, which include Nurofen tablets and Durex condoms, rose 7.5%. Volumes declined 4.1% compared with last year.
Persons: Andrew Kelly, Reckitt, Kris Licht, Bernstein, Bruno Monteyne, Richa Naidu, Jason Neely, David Evans, Helen Popper Our Organizations: Benckiser, REUTERS, Wednesday, Thomson Locations: Manhattan , New York City, U.S
☆ Reckitt names Kris Licht as CEO, beats sales estimates
  + stars: | 2023-04-26 | by ( ) www.reuters.com   time to read: +2 min
LONDON, April 26 (Reuters) - Reckitt Benckiser (RKT.L) has named company insider Kris Licht as CEO designate to succeed Nicandro Durante, taking the helm by the end of the year after a transition period. Licht, who has served as president of Reckitt's health business and as chief customer officer since July 2020, will be appointed to the board as an executive director from June 1. Durante, a former BAT (BATS.L) chief executive, will stay with Reckitt until December "to ensure a smooth transition". The company, which makes Durex condoms and Lysol cleaning products, also reported like-for-like net revenue up 7.9% in the first quarter, beating analyst expectations of a 3.6% rise in consensus forecast provided by the company. Reckitt, which also makes Nurofen tablets, cold remedy Lemsip and Dettol hygiene products, now expects like-for-like net revenue growth of 3-5% for the year after beating sales expectations for several quarters in a row, helped by price increases.
☆ Reckitt CEO switch may boost odds of a takeover
  + stars: | 2023-04-26 | by ( ) www.reuters.com   time to read: +2 min
LONDON, April 26 (Reuters Breakingviews) - Reckitt Benckiser’s (RKT.L) decision to appoint an insider as CEO may help to entice prospective buyers, like U.S. giant Procter & Gamble (PG.N). Reckitt has been a perennial takeover target, as previous bosses struggled to deliver consistently strong revenue growth. It is still paying down a hefty debt pile following an ill-advised $17 billion takeover of baby food maker Mead Johnson in 2017. Net revenue grew by nearly 8% year-on-year in the first quarter – after excluding acquisitions, disposals and currency fluctuations. Reckitt’s shares trade at 17 times forecast 2023 earnings, compared with P&G’s multiple of nearly 25 times.
☆ Global recession fears weigh on UK stocks; Persimmon rallies
  + stars: | 2023-04-26 | by ( Shristi Achar A | Thomson Reuters | Shristi Is A Correspondent | ) www.reuters.com   time to read: +2 min
The blue-chip index (.FTSE) fell 0.3%, down for the third straight session, while the mid-cap FTSE 250 (.FTMC) shed 0.4% as of 0829 GMT. The FTSE 100 had a good run earlier this month, buoyed by strength in commodity stocks and defensives like pharmaceuticals. However, markets have taken to a wait-and-see mode as earnings kicked in, to assess the impact of monetary tightening on results. Oil and gas stocks (.FTNMX601010) rose 0.6% as crude prices gained on reports of falling U.S. crude oil and fuel inventories. Drax Group's shares (DRX.L) rose 3.8% after the power generator announced a 150 million pound ($187 mln) share buyback programme.
0 next >>
Total: 5